German court deals blow to Sanofi over cholesterol drug

A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

US court backs Sanofi and Regeneron in Amgen suit

29 August 2019 A US judge yesterday, August 28 ruled in favour of Sanofi and Regeneron in the pharmaceutical companies’ long-running patent dispute with Amgen over the cholesterol drug Praluent.

Americas

Sanofi victorious at Fed Circ in prostate cancer drug dispute

15 August 2019 Sanofi secured a win at the US Court of Appeals for the Federal Circuit yesterday, August 14, after the appeals court concluded a lower court lacked authority to invalidate claims of a patent covering a prostate cancer drug.

Big Pharma

German Court rules Sanofi’s Praluent infringes Amgen patent

12 July 2019 A German court has found that Sanofi’s high-cholesterol treatment, Praluent, infringes one of Amgen’s patents.

More on this story

Americas

US court backs Sanofi and Regeneron in Amgen suit

29 August 2019 A US judge yesterday, August 28 ruled in favour of Sanofi and Regeneron in the pharmaceutical companies’ long-running patent dispute with Amgen over the cholesterol drug Praluent.

Americas

Sanofi victorious at Fed Circ in prostate cancer drug dispute

Big Pharma

German Court rules Sanofi’s Praluent infringes Amgen patent

12 July 2019 A German court has found that Sanofi’s high-cholesterol treatment, Praluent, infringes one of Amgen’s patents.

More on this story

Americas

US court backs Sanofi and Regeneron in Amgen suit

29 August 2019 A US judge yesterday, August 28 ruled in favour of Sanofi and Regeneron in the pharmaceutical companies’ long-running patent dispute with Amgen over the cholesterol drug Praluent.

Americas

Sanofi victorious at Fed Circ in prostate cancer drug dispute

Big Pharma

German Court rules Sanofi’s Praluent infringes Amgen patent

12 July 2019 A German court has found that Sanofi’s high-cholesterol treatment, Praluent, infringes one of Amgen’s patents.